BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.50
-0.70 (-2.48%)
Last updated: Mar 13, 2026, 2:41 PM CET
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 164.91 million as of March 13, 2026. Its market cap has decreased by -21.23% in one year.
Market Cap
164.91M
Enterprise Value
91.09M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.50
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 164.91M, a decrease of -20.68%. That is a compound annual growth rate of -19.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 135.09M | -5.33% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 889.08M |
| Basilea Pharmaceutica AG | 649.00M |
| Newron Pharmaceuticals | 363.28M |
| Santhera Pharmaceuticals Holding AG | 237.31M |
| Molecular Partners AG | 140.25M |
| Xlife Sciences AG | 132.65M |
| EvoNext Holdings | 6.29M |
| Addex Therapeutics | 5.20M |